Xtant Medical Holdings, Inc. Income Statement
XTNT|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Xtant Medical Holdings, Inc. reported $117M in revenue and $16M in net loss for FY2025. Revenue has grown at a 15.6% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117.3M | $91.3M | $58.0M | $55.3M | $53.3M | $64.7M | $72.2M | $82.6M | $90.0M | $59.3M | $35.3M | $33.1M | $33.0M | $30.1M | $15.4M |
| Cost of Revenue | $49.1M | $35.8M | $25.8M | $22.8M | $18.9M | $22.2M | $28.7M | $32.5M | $27.7M | $20.3M | $13.0M | $14.2M | $10.3M | $9.1M | $3.4M |
| Gross Profit | $68.2M | $55.5M | $32.1M | $32.5M | $34.4M | $42.5M | $43.5M | $50.1M | $62.3M | $39.1M | $22.3M | $18.9M | $22.6M | $21.0M | $12.1M |
| SG&A Expense | $28.7M | $25.9M | $15.5M | $14.4M | $13.5M | $17.3M | $14.3M | $15.2M | $15.8M | $13.0M | $8.9M | $10.2M | $11.1M | $6.9M | $8.5M |
| R&D Expense | $2.4M | $1.3M | $915.0K | $870.0K | $657.0K | $932.0K | $1.7M | $2.4M | $3.4M | $2.5M | $1.4M | $572.4K | - | - | - |
| Operating Income | -$12.1M | -$10.2M | -$6.8M | -$3.9M | -$751.0K | -$2.3M | -$60.1M | -$37.8M | -$7.5M | -$12.1M | -$6.3M | -$9.0M | -$4.9M | -$6.5M | -$8.6M |
| Interest Expense | $4.2M | $2.9M | $1.7M | $995.0K | $6.0M | $5.8M | $10.1M | $14.7M | $12.3M | $7.7M | $5.7M | $4.7M | $1.9M | $1.2M | $1.6M |
| Income Tax | $187.0K | -$1.7M | $69.0K | $69.0K | $296.0K | $98.0K | -$98.0K | - | $50.4K | -$17.5M | $0 | $0 | $0 | - | - |
| Net Income | -$16.4M | $660.0K | -$8.5M | -$4.8M | -$7.0M | -$8.2M | -$70.1M | -$52.4M | -$19.5M | -$2.2M | -$10.5M | -$12.7M | -$7.7M | -$3.0M | -$19.5M |
| EPS (Basic) | -$0.12 | $0.01 | -$0.09 | -$0.06 | -$0.25 | -$0.63 | -$5.97 | -$34.76 | -$18.46 | -$0.24 | -$1.76 | -$2.80 | -$0.18 | -$0.08 | -$0.61 |
| EPS (Diluted) | -$0.12 | $0.01 | -$0.09 | -$0.06 | -$0.25 | -$0.63 | -$5.97 | -$34.76 | -$18.46 | -$0.24 | -$1.76 | -$2.80 | -$0.18 | -$0.08 | -$0.61 |
| Shares Outstanding | 139.0M | 130.2M | 108.9M | 87.1M | 77.6M | 13.2M | 13.2M | 1.5M | 1.4M | 11.9M | 6.7M | 5.3M | 42.9M | 40.8M | 37.0M |
| Gross Margin | 58.2% | 60.8% | 55.4% | 58.8% | 64.5% | 65.7% | 60.2% | 60.7% | 69.2% | 65.9% | 63.1% | 57.1% | 68.7% | 69.8% | 78.2% |
| Operating Margin | -10.3% | -11.1% | -11.7% | -7.0% | -1.4% | -3.5% | -83.2% | -45.8% | -8.4% | -20.3% | -17.7% | -27.2% | -15.0% | -21.4% | -55.9% |
| Profit Margin | -14.0% | 0.7% | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% | -3.7% | -29.7% | -38.4% | -23.4% | -10.0% | -126.3% |